Codexis CEO Stephen Dilly Wins Prestigious 2023 Bloom Burton Award
September 29, 2023 07:05 ET
|
Codexis, Inc.
REDWOOD CITY, Calif., Sept. 29, 2023 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading enzyme engineering company, today announced President and Chief Executive Officer Stephen Dilly,...
Codexis CEO Stephen Dilly Named as Finalist of 2023 Bloom Burton Award
September 18, 2023 16:05 ET
|
Codexis, Inc.
REDWOOD CITY, Calif., Sept. 18, 2023 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading enzyme engineering company, today announced Stephen Dilly, MBBS, PhD, President and Chief Executive...
Codexis to Participate in Cantor Global Healthcare Conference
September 12, 2023 16:05 ET
|
Codexis, Inc.
REDWOOD CITY, Calif., Sept. 12, 2023 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading enzyme engineering company, today announced the Company will attend the Cantor Global Healthcare...
Codexis Announces Agreement for Assignment and Assumption of San Carlos Facility Lease
September 07, 2023 16:05 ET
|
Codexis, Inc.
REDWOOD CITY, Calif., Sept. 07, 2023 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading enzyme engineering company, today announced the Company has executed an Assignment and Assumption of...
Codexis Reports Second Quarter 2023 Financial Results
August 03, 2023 16:05 ET
|
Codexis, Inc.
Company Recently Announced Enhanced Strategic Focus and Portfolio Prioritization Anticipate Demonstrating Gram-Scale Synthesis of ECO Synthesis™ Technology for RNAi Therapeutics...
Codexis Documentary Showcases its Specialized Capabilities Engineering High Performance Enzymes to Enable Delivery of Novel Therapeutics
July 31, 2023 16:05 ET
|
Codexis, Inc.
REDWOOD CITY, Calif., July 31, 2023 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading enzyme engineering company, today announced the launch of a new mini documentary as part of an ongoing...
Codexis Announces Enhanced Strategic Focus and Extends Projected Cash Runway to Mid-2026
July 20, 2023 16:05 ET
|
Codexis, Inc.
Organization Streamlined to Focus on Continued Advancement and Commercialization of ECO Synthesis™ Platform for RNAi Therapeutics Production Codexis Expects its Pharmaceutical Manufacturing Business...
Codexis Announces New Employment Inducement Grants
June 09, 2023 16:05 ET
|
Codexis, Inc.
REDWOOD CITY, Calif., June 09, 2023 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading enzyme engineering company, today announced the approval of equity grants to four new employees as...
Codexis to Participate in Jefferies Healthcare Conference
May 24, 2023 16:05 ET
|
Codexis, Inc.
REDWOOD CITY, Calif., May 24, 2023 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading enzyme engineering company, today announced the Company will attend the Jefferies Healthcare...
Codexis Unveils ECO Synthesis™ Platform for Large-Scale RNAi Therapeutics Production at TIDES USA
May 10, 2023 16:05 ET
|
Codexis, Inc.
REDWOOD CITY, Calif., May 10, 2023 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading enzyme engineering company, today announced the unveiling of its Enzyme-Catalyzed Oligonucleotide (ECO)...